Search results for "Virology"

showing 10 items of 2354 documents

Estudio de alteraciones fisiológicas y bioquímicas causadas por el viroide de la exocortis de los cítricos (CEV) en huéspedes herbáceos...

1985

Biology VirologyUNESCO::CIENCIAS DE LA VIDA:CIENCIAS DE LA VIDA [UNESCO]
researchProduct

Anticuerpos funcionales contra el Citomegalovirus humano (CMVH) en el paciente infectado por el virus de la inmunodeficiencia humana (VIH-1) en prese…

2000

Biology VirologyUNESCO::CIENCIAS DE LA VIDA:CIENCIAS DE LA VIDA [UNESCO]
researchProduct

Viroide exocortis de los cítricos (CEV) : inespecificidad de las alteraciones protéicas asociadas a la interacción viroide-huésped

1982

Biology VirologyUNESCO::CIENCIAS DE LA VIDAAgriculture Plant Pathology:CIENCIAS DE LA VIDA [UNESCO]
researchProduct

Caracterización de cepas ambientales de Vidrio cholerae no 01 : factores relacionados con su supervivencia y virulencia

1987

Biology VirologyUNESCO::CIENCIAS DE LA VIDABiology Microbiology:CIENCIAS DE LA VIDA [UNESCO]Environmental Sciences
researchProduct

DNA-mediated immunization to hepatitis B virus envelope proteins: preS antigen secretion enhances the humoral response.

1999

In order to design optimized DNA vectors as genetic vaccines against infections with the hepatitis B virus (HBV) we investigated if secretion or retention of the viral antigens has an influence on the quality and quantity of the humoral immune response. Intramuscular injection of plasmid DNA encoding the HBV large L envelope protein, known to be retained within host cells, induced only a weak response in mice whereas a vector expressing the secretion-competent small S envelope protein elicited strong and sustained immunity. Immunization with rearranged envelope genes further demonstrated that secretion affects the magnitude of the immune response. In situ expression of modified small and mi…

Biologymedicine.disease_causeEpitopeVirusMiceImmune systemAntigenAdjuvants ImmunologicViral Envelope ProteinsmedicineVaccines DNAAnimalsHepatitis B VaccinesHepatitis B AntibodiesProtein PrecursorsHepatitis B virusMice Inbred BALB CHepatitis B Surface AntigensGeneral VeterinaryGeneral Immunology and MicrobiologyImmunogenicityPublic Health Environmental and Occupational HealthVirologyMolecular biologyInfectious DiseasesHumoral immunityCOS Cellsbiology.proteinMolecular MedicineFemaleAntibodyVaccine
researchProduct

NOVEL COMPOSED GALACTOSYLATED NANODEVICES CONTAINING A RIBAVIRIN PRODRUG AS HEPATIC CELL-TARGETED CARRIERS FOR HCV TREATMENT

2013

In this paper, we describe the preparation of liver-targeted nanoparticles potentially able to carry to hepatocytes a ribavirin (RBV) prodrug, exploiting the presence of carbohydrate receptors in the liver (i.e., ASGPR in hepatocytes). These particles were obtained starting from a galactosylated phospholipid-polyaminoacid conjugate. This latter was obtained by chemical reaction of ALPHA, BETA -poly(N-2-hydroxyethyl) (2-aminoethylcarbamate)-DL-aspartamide (PHEA-EDA) with 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(succinyl) sodium salt (DPPE), and subsequent reaction with lactose, obtaining PHEA-EDA-DPPE-GAL copolymer. To enhance the entrapment into obtained nanostructures, a hydroph…

Biomedical EngineeringPharmaceutical ScienceMedicine (miscellaneous)NanoparticleBioengineeringAntiviral AgentsDiffusionNon-competitive inhibitionNanocapsulesMaterials TestingRibavirinHumansGeneral Materials ScienceProdrugschemistry.chemical_classificationGalactoseHep G2 CellsProdrugCarbohydrateVirologyCombinatorial chemistryHepatitis CIn vitroGalactosylated Nanoparticles Hepatic Cell-Targeted Carriers Active Targeting Ribavirin Tripalmitate Hepatitis C.EnzymechemistrySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoDrug deliveryConjugate
researchProduct

Scientific HIV research in Africa and the Middle East: a socio-economic demographic analysis

2021

Background: In Africa, HIV/AIDS research is concentrated in certain countries, particularly South Africa. This distribution may not accurately reflect the disease prevalence or the true research efforts of countries.Objectives: To identify HIV/AIDS research productivity of countries in Africa and the Middle East, in absolute terms and adjusted for people living with HIV, population size and economic development.Methods: We identified all the articles and reviews on HIV and AIDS in the Web of Science Core Collection in which African or Middle Eastern countries had participated. After determining the number of documents produced by each country, we adjusted the findings for the number of peop…

Biomedical ResearchPrevalenceDistribution (economics)HIV InfectionsEfficiencyGross domestic productMiddle East03 medical and health sciences0302 clinical medicineAcquired immunodeficiency syndrome (AIDS)Virologyparasitic diseasesPrevalencemedicineHumans030212 general & internal medicineSocioeconomicsDeveloping CountriesProductivity030505 public healthMiddle Eastbusiness.industryPublic Health Environmental and Occupational HealthGeneral Medicinemedicine.diseaseDemographic analysisInfectious DiseasesGeographyGross national incomeSocioeconomic FactorsAfrica0305 other medical sciencebusinessAfrican Journal of AIDS Research
researchProduct

Detection of tick-borne encephalitis virus in I. ricinus ticks collected from autumn migratory birds in Latvia.

2014

Birds have a potential of spreading ticks via bird migration routes. In this study, we screened 170 ticks removed during autumn 2010 from 55 birds belonging to 10 species for the presence of tick-borne encephalitis virus (TBEV). In total, TBEV RNA was detected in 14% of I. ricinus tick samples obtained from different birds species. The results of this study indicate the possible role of migrating birds in the dispersal of TBEV-infected ticks along the southward migration route.

Bird migrationBiologyTickMicrobiologyVirusEncephalitis Viruses Tick-BorneBirdsZoonosesparasitic diseasesmedicineAnimalsHumansIxodesBird DiseasesRicinusbacterial infections and mycosesmedicine.diseasebiology.organism_classificationVirologyLatviaTick-borne encephalitis virusInfectious DiseasesInsect ScienceBiological dispersalRNA ViralParasitologyAnimal MigrationArachnid VectorsSeasonsEncephalitisEncephalitis Tick-BorneTicks and tick-borne diseases
researchProduct

Antiidiotypic DNA vaccination induces serum bactericidal activity and protection against group B meningococci

2006

No vaccine is available for preventing infections by serogroup B Neisseria meningitidis (MenB), which accounts for a major portion of meningococcal cases in developed countries, because of the poor immunogenicity of the capsular polysaccharide (CP) even after protein conjugation. We have previously induced anticapsular antibodies by immunization with a single chain variable fragment (scFv), which mimics a protective CP epitope. This surrogate antigen, however, was ineffective at inducing serum bactericidal activity, an accepted marker of protection in humans. Serum bactericidal activity was consistently achieved by immunizing mice with the scFv-encoding gene. Immunization with vectors witho…

Blood Bactericidal ActivityImmunologyImmunoglobulin Variable Regionchemical and pharmacologic phenomenaBlood Bactericidal ActivityNeisseria meningitidis Serogroup BEpitopeArticleMicrobiologyDNA vaccinationMiceAntigenserogroup B Neisseria meningitidis; single chain variable fragment; DNA vaccinationChlorocebus aethiopsVaccines DNAImmunology and AllergyAnimalsRats WistarMice Inbred BALB CbiologyImmunogenicityArticlesVirologyAntibodies BacterialRatsBacterial vaccineMeningococcal InfectionsImmunizationAnimals NewbornBacterial VaccinesCOS Cellsbiology.proteinAntibody
researchProduct

Routine HCV PCR screening of blood donations to identify early HCV infection in blood donors lacking antibodies to HCV

2001

BACKGROUND: Detection of early hepatitis C infection of blood donors is still a major problem for blood transfusion. Common anti-HCV screening assays show differences in sensitivity and specificity. The often mild symptoms of acute hepatitis C also cause difficulties in the identification of early HCV infection. The feasibility and efficacy of routine screening of blood donations for HCV RNA were investigated. STUDY DESIGN AND METHODS: Blood donations (n = 251,737) were screened for HCV RNA over 4 years. RNA extraction, amplification, and detection were done by two commercial HCV PCR kits (HCV Cobas Amplicor and HCV Cobas Amplicor 2.0, Roche Diagnostics). Screening was done by pool testing …

Blood transfusionmedicine.medical_treatmentHepacivirusImmunologyBlood DonorsHepacivirusPolymerase Chain ReactionSensitivity and SpecificitySerologymedicineHumansMass ScreeningImmunology and AllergyAspartate AminotransferasesMass screeningbiologybusiness.industryvirus diseasesAlanine TransaminaseHematologyHepatitis CHepatitis C Antibodiesbiology.organism_classificationmedicine.diseaseHepatitis CVirologydigestive system diseasesImmunologybiology.proteinFeasibility StudiesRNA ViralRNA extractionViral diseaseAntibodybusinessFollow-Up StudiesTransfusion
researchProduct